ARDELYX, INC.
ARDXLoading price...
Overview
Previous Close--
Open--
Ask--
Bid--
Day's Range -
52 Week Range -
PE Ratio(TTM)--
Market Cap--
Volume--
Avg. Volume--
Profit/Loss
| PARTICULARS | ||||||
|---|---|---|---|---|---|---|
| No results to display | ||||||
Company Profile
Sector: Healthcare
Industry: Biotechnology
HQ Location: Waltham, United States
Website: https://www.ardelyx.com
President, CEO & Director: Mr. Michael G. Raab
Employees: 489
About Company:
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.